|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
29 June 2015 |
|
Main ID: |
NCT02134652 |
|
Date of registration:
|
29/04/2014 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
|
|
Scientific title:
|
Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever |
|
Date of first enrolment:
|
January 2015 |
|
Target sample size:
|
0 |
|
Recruitment status: |
Withdrawn |
|
URL:
|
http://clinicaltrials.gov/show/NCT02134652 |
|
Study type:
|
Observational |
|
Study design:
|
Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Cambodia
| | | | | | | |
|
Contacts
|
|
Name:
|
Romolo Gaspari, M.D., Ph.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Massachusetts, Worcester |
|
|
Name:
|
Samuel D Licciardo, M.D. |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Massachusetts, Worcester |
| |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. Age >3 months and <16 years
2. Clinical suspicion of dengue hemorrhagic fever. (Revised WHO Classification System)
3. Not a prisoner or ward of the state
4. Parents able and willing to give consent. Children older then 7 able and willing to
give assent
Exclusion Criteria:
1. Allergic to Ultrasound gel
2. Prisoners or wards of the state
3. Unstable patients
4. Known pleural effusion, ascites, or gallbladder wall thickening.
Age minimum:
3 Months
Age maximum:
16 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Dengue
|
|
Disease Progression
|
|
Intervention(s)
|
|
Other: diagnostic bedside ultrasound
|
|
Primary Outcome(s)
|
|
Progression of Disease
[Time Frame: Patients who are discharged from home will be contacted a maximum of 10 days after discharge to acquire follow up data. Those patients who are admitted to the hospital will monitored for the entirety of their hospital stay, an average of about 2 weeks.]
|
|
Secondary Outcome(s)
|
|
Clinical Care
[Time Frame: Patients will receive an ultrasound in the emergency department or outpatient department. Within 2 hours of study enrollment, the treating physician will be made aware of the test results and will be queried for changes in decision making.]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|